Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

5.705
-0.045-0.78%
Volume:5.20M
Turnover:29.86M
Market Cap:9.11B
PE:-18.13
High:5.860
Open:5.750
Low:5.600
Close:5.750
52wk High:13.150
52wk Low:4.010
Shares:1.60B
HK Float Shares:1.60B
Volume Ratio:0.54
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.315
ROE:-52.14%
ROA:-14.44%
PB:6.04
PE(LYR):-18.13
PS:18.36

Loading ...

A Look At CStone Pharmaceuticals (SEHK:2616) Valuation After Pralsetinib’s First Domestic Launch In China

Simply Wall St.
·
May 25

CStone Pharmaceuticals Plans Share Buyback

MT Newswires Live
·
May 13

CStone Announces Plan to Repurchase up to 136.45 Million Shares After ASCO Meeting

Bulletin Express
·
May 13

CSTONE PHARMA-B Announces Plan to Repurchase Up to 136 Million Shares

Stock News
·
May 13

CStone Pharmaceuticals - to Repurchase up to 136.5 Mln Shares in Open Market Under General Mandate

THOMSON REUTERS
·
May 13

CStone Pharmaceuticals plans market buyback of up to 136,450,133 shares

Reuters
·
May 13

CStone Pharmaceuticals Begins Commercial Distribution of Locally Manufactured Pralsetinib

MT Newswires Live
·
May 11

CSTONE PHARMA-B Initiates Nationwide Commercial Distribution of Locally Produced Pralsetinib Capsules

Stock News
·
May 11

CStone launches nationwide distribution of China-made pralsetinib; projects 2026 sales above RMB 0.30 billion

Bulletin Express
·
May 11

CStone expects 2026 pralesatinib capsule sales revenue to top CNY 300 million

Reuters
·
May 11

CStone Pharmaceuticals - Begins Nationwide Commercial Supply of Locally Manufactured Pralsetinib Capsules

THOMSON REUTERS
·
May 11

CStone Pharma Issues 124.23 Million New Shares in April, Expanding Share Base to 1.60 Billion

Bulletin Express
·
May 07

Stock Track | CStone Pharmaceuticals-B Plummets 5.17% Intraday on Share Placement Dilution and Widening Annual Losses

Stock Track
·
Apr 28

CSTONE PHARMA-B 2025年净亏损达4.37亿元,创新管线投入加速推进

Bulletin Express
·
Apr 27

CStone Pharmaceuticals publishes 2025 annual report

Reuters
·
Apr 27

Stock Track | CStone Pharma-B Plummets 5.90% Intraday on Share Placement Dilution Concerns

Stock Track
·
Apr 24

CStone Pharmaceuticals raises HK$1.05 billion through placing of 118 million new shares, expanding capital base by 7.40%

Bulletin Express
·
Apr 22

CSTONE PHARMA-B Allots 118 Million New Shares Under Placement Agreement

Stock News
·
Apr 22

CStone files HKEX next-day return for 118,000,000-share issue at HKD 8.97

Reuters
·
Apr 22

Stock Track | CSTONE PHARMA-B Soars 5.10% Intraday on Positive CS2009 Clinical Data for ASCO Presentation

Stock Track
·
Apr 22